Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Recurrent Metastatic Non-Squamous Non Small Cell Lung Cancer 1Prostatic Neoplasms 1Leukemia, Myeloid, Acute 1Leiomyoma 1Breast Neoplasms 1Agnosia 1Abdominal Cancer 1

Interventions

Bupivacaine 11Ketamine 9Ropivacaine 8Acetaminophen 8Morphine 7Dexmedetomidine 7Analgesics, Opioid 7Lidocaine 6Anesthesia, General 6Saline Solution 5Fentanyl 5Anesthesia, Local 5Acupuncture Therapy 5parecoxib 4Tramadol 4Surveys and Questionnaires 4Sodium Chloride 4Ethanol 4Analgesia, Epidural 4Transcutaneous Electric Nerve Stimulation 3Radiofrequency Ablation 3Propofol 3Oxycodone 3Ketorolac 3Control Groups 3Anesthetics, Local 3Therapeutics 2Tea 2Pregabalin 2Magnesium Sulfate 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Agnosia × Injections, Subcutaneous × Clear all
NCT02270255 2019-08-14

Superior Hypogastric Nerve Block for Pain Control Post-uterine Fibroid Embolization

McGill University Health Centre/Research Institute of the McGill University Health Centre

Phase 2 Completed
44 enrolled 8 charts

Agnosia, Leiomyoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡